Publication:
Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice.

cris.virtual.author-orcid0000-0003-3650-6153
cris.virtualsource.author-orcidd63db0fd-39fd-4ba4-a8d8-db576a5f09d6
cris.virtualsource.author-orcid686d3017-7cf3-4eb6-ba91-512488e68e6c
cris.virtualsource.author-orcid963d336c-05b4-423c-9fab-8dbcee1243ba
cris.virtualsource.author-orcid12fd15d3-2029-451c-ba7a-8a10c9c7c993
cris.virtualsource.author-orcid106e13fd-a3d9-46cd-b280-04849a6a79b7
cris.virtualsource.author-orcid52ac6940-1f8a-4701-afd0-2353347f9ca6
cris.virtualsource.author-orcid1db177e5-b0b4-4b1c-b039-8b18d729f454
datacite.rightsopen.access
dc.contributor.authorGuarino, Maria
dc.contributor.authorKumar, Pavitra
dc.contributor.authorFelser, Andrea Debora
dc.contributor.authorTerracciano, Luigi M
dc.contributor.authorGuixé Muntet, Sergi
dc.contributor.authorHumar, Bostjan
dc.contributor.authorFoti, Michelangelo
dc.contributor.authorNuoffer, Jean-Marc
dc.contributor.authorSt-Pierre, Marie
dc.contributor.authorDufour, Jean-François
dc.date.accessioned2024-09-20T09:19:52Z
dc.date.available2024-09-20T09:19:52Z
dc.date.issued2020-05-29
dc.description.abstractNon-alcoholic fatty liver disease (NAFLD) leads to steatohepatitis (NASH), fibrosis, and hepatocellular carcinoma. For sedentary patients, lifestyle interventions combining exercise and dietary changes are a cornerstone of treatment. However, the benefit of exercise alone when dietary changes have failed is uncertain. We query whether exercise alone arrests the progression of NASH and tumorigenesis in a choline-deficient, high-fat diet (CD-HFD) murine model. Male C57Bl/6N mice received a control diet or CD-HFD for 12 weeks. CD-HFD mice were randomized further for 8 weeks of sedentariness (SED) or treadmill exercise (EXE). CD-HFD for 12 weeks produced NAFL. After 20 weeks, SED mice developed NASH and hepatic adenomas. Exercise attenuated the progression to NASH. EXE livers showed lower triglycerides and tumor necrosis factor-α expression, less fibrosis, less ballooning, and a lower NAFLD activity score than did SED livers. Plasma transaminases and triglycerides were lower. Exercise activated AMP-activated protein kinase (AMPK) with inhibition of mTORC1 and decreased S6 phosphorylation, reducing hepatocellular adenoma. Exercise activated autophagy with increased LC3-II/LC3-I and mitochondrial recruitment of phosphorylated PTEN-induced kinase. Therefore, exercise attenuates the transition from NAFL to NASH, improves biochemical and histological parameters of NAFLD, and impedes the progression of fibrosis and tumorigenesis associated with enhanced activation of AMPK signaling and favors liver autophagy. Our work supports the benefits of exercise independently of dietary changes.
dc.description.sponsorshipUniversitätsinstitut für Klinische Chemie (UKC)
dc.description.sponsorshipDepartment for BioMedical Research, Hepatologie Forschung
dc.identifier.doi10.7892/boris.147773
dc.identifier.pmid32486073
dc.identifier.publisherDOI10.3390/cancers12061407
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/45086
dc.language.isoen
dc.publisherMDPI AG
dc.relation.ispartofCancers
dc.relation.issn2072-6694
dc.relation.organizationDCD5A442C6DFE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BBC5E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BA49E17DE0405C82790C4DE2
dc.subjectER stress exercise high-fat diet non-alcoholic fatty liver disease (NAFLD)
dc.subjectnon-alcoholic steatohepatitis (NASH)
dc.subjecthepatocellular carcinoma (HCC)
dc.subjectliver fibrosis
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleExercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice.
dc.typearticle
dspace.entity.typePublication
oaire.citation.issue6
oaire.citation.volume12
oairecerif.author.affiliationDepartment for BioMedical Research, Hepatologie Forschung
oairecerif.author.affiliationDepartment for BioMedical Research, Hepatologie Forschung
oairecerif.author.affiliationUniversitätsinstitut für Klinische Chemie (UKC)
oairecerif.author.affiliationDepartment for BioMedical Research, Hepatologie Forschung
oairecerif.author.affiliationUniversitätsinstitut für Klinische Chemie (UKC)
oairecerif.author.affiliationDepartment for BioMedical Research, Hepatologie Forschung
oairecerif.author.affiliationDepartment for BioMedical Research, Hepatologie Forschung
oairecerif.author.affiliation2Universitätsklinik für Viszerale Chirurgie und Medizin, Hepatologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2020-11-09 13:48:26
unibe.description.ispublishedpub
unibe.eprints.legacyId147773
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
cancers-12-01407-v2 (1).pdf
Size:
8.7 MB
Format:
Adobe Portable Document Format
License:
https://creativecommons.org/licenses/by/4.0
Content:
published

Collections